Sanofi »

First Tracks Biotherapeutics shares owned by Sanofi

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Sanofi from 13F filings

Historical chart of Sanofi investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Sanofi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Sanofi

Quarter filed Position value Share count Share price at filing
2026-06-30 $17M 822k 20.12

More positions owned by Sanofi

Meiragtx Holdings (MGTX)
Inhibrx Biosciences (INBX)
Novavax Com New (NVAX)
Anaptysbio Inc Common (ANAB)
Odyssey Therapeutics Common Stock
Agomab Therapeutics NV Sponsored Ads (AGMB)
Maplight Therapeutics (MPLT)
First Tracks Biotherapeutics Ord Shs (TRAX)
Immuneering Corp Class A Com (IMRX)
Q32 Bio (QTTB)

View all positions for Sanofi

Top funds holding First Tracks Biotherapeutics

Sanofi
Financial Enhancement
Moody Aldrich Partners
Tema Etfs
New York State Common Retirement Fund
China Universal Asset Management
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
GAMMA Investing
Sterling Capital Management
EverSource Wealth Advisors
Adirondack Trust
Massmutual Trust
Signature
True Wealth Design

View all funds holding First Tracks Biotherapeutics